Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference20 articles.
1. Bernard J, Boiron M, Jacquillat C, Weil M, Najean Y. Un nouvel agent actif dans le traitement des leucémies aiguës: la cytosine arabinoside. Presse Med. 1966;74:799–802.
2. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood. 1968;32:507–23.
3. Lamba JK. Genetic factors influencing cytarabine therapy. Pharmacogenomics. 2009;10:1657–74.
4. Abraham A, Varatharajan S, Karathedath S, Philip C, Lakshmi KM, Jayavelu AK, et al. RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia. Pharmacogenomics. 2015;16:877–90.
5. Yates JW, Wallace HJ Jr, Ellison RR, Holland JF. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep. 1973;57:485–8.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献